30.11.2022
Early Christmas Dinner…
…and joint visit to the Tübingen chocolate market.
We celebrate very successful and eventful year full of exciting research results, great conferences and meetings, and amazing collaborations.
Many thanks to the entire team and our collaborators!
22.10.2022
Lisa is among this year’s ERC Starting Grant awardees
In our project “gutMAP”, we aim to investigate the influence of the gut microbiome on the effect of psychotropic drugs. The project is funded by a Starting Grant of the European Research Council (ERC) with a total of about 1.5 million euros
© Leon Kokkoliadis / Cluster of Excellence CMFI
01.04.2022
Our junior research group is growing into a full professorship!
Lisa got promoted to full professor for Microbiome-Host-Interactions at the Medical Faculty of the University of Tübingen! What a fantastic opportunity to expand our research, our team and our mission!
20.01.2022
New board game: Antibio`taktik!
The board game “Antiobio`taktik” is intended to raise awareness of the problem of antibiotic resistance. It was co-developed by our team member Nalini and is now available in German and French. Contact us if you are interested.
14.12.2021
Article about our work in Laborjournal
Larissa Tetsch summarized our work for the broader audience in Laborjournal, a German magazine aimed at scientific and technical staff in biological and medical laboratories (in German).
13.10.2021
Deciphering the collateral damage of antibiotics on human gut commensals
Press release highlighting our 2021 study.
01.09.2021
Our work is featured in the podcast series “Exzellent erklärt! – Spitzenforschung für alle”
In the podcast series, the interdiscplinary work of each of the 57 German Cluster of Excellence is highlighted. For the episode on the Cluster “Controlling Microbes to Fight Infections”, Lisa was interviewed by the podcaster Larissa Vassilian.
19.03.2018
Non-Antibiotic Drugs Affect our Gut Bacteria
e-learning video showcasing the idea, approach and results of our 2018 study on the extensive effect of non-antibiotic drugs on human gut bacteria.